PulmonaRy Inflammation and glucocorticoiD sensItivity for the prediCTion of BronchoPulmonary Dysplasia (PRIDICT-BPD): a feasibility study.

PulmonaRy Inflammation and glucocorticoiD sensItivity for the prediCTion of BronchoPulmonary Dysplasia (PRIDICT-BPD): a feasibility study. - Pulmonary inflammation and Glucocorticoid sensitivity in preterm infants

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49781

Enrollment

Registered

2019-09-20

Start date

2019-10-28

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary dysplasia chronic lung disease of prematurity

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Newborn infant born

Exclusion criteria

Exclusion criteria: Congenital anomalies of any kind Major surgery within 24 hours after birth

Design outcomes

Primary

Measure	Time frame
* To test whether the assays described above are feasible in this patient group	—

Secondary

Measure	Time frame
* To test whether the outcomes on the assays are associated with the development of BPD and the duration of respiratory support; * To test whether the outcomes on these assays are associated with pro-inflammatory markers;	—

Countries

Netherlands

Outcome results